ChemDAQ, a specialist in hazardous gas monitoring technologies, has entered into a strategic partnership with Doha-based Sedeer Medical, a healthcare solutions provider and medical equipment distributor
The collaboration aims to extend ChemDAQ’s reach in the Middle East by introducing its continuous, real-time chemical monitoring systems to new regional markets.
As part of the agreement, Sedeer Medical will distribute ChemDAQ’s gas detection solutions across the region, expanding access to advanced workplace safety technologies within healthcare environments. The systems support continuous monitoring in facilities where hazardous gases and chemicals, including ethylene oxide (EtO), hydrogen peroxide (H2O2), and peracetic acid (PAA), are used.
“Partnering with ChemDAQ allows us to offer world-class chemical monitoring solutions to our customers,” said Ramees Vadakkettil, Senior Service Engineer at Sedeer.
“By introducing ChemDAQ's proven monitoring technology to our region, we help hospitals proactively manage risks and ensure the safety of their workforce.”
Alex Hilliker, Executive vice-president at ChemDAQ, added, “Sedeer Medical's expertise and stellar reputation in the region make them the ideal partner to help ChemDAQ grow in this market. This collaboration expands access to our continuous monitoring solutions for hospitals in the Middle East, increasing our global footprint and supporting safer workplaces worldwide.”
The partnership highlights a shared commitment by both organisations to strengthening workplace safety standards and enabling proactive risk management, ensuring more hospitals can benefit from reliable, real-time hazardous gas detection.
